Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Tempus AI, Inc. - Class A Common Stock (NQ: TEM ) 73.77 +16.98 (+29.90%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Tempus AI, Inc. - Class A Common Stock Tempus Announces Nine Abstracts Accepted for Presentation at the 2024 Society for Immunotherapy of Cancer Annual Meeting November 08, 2024 From Tempus AI, Inc. Via Business Wire Tempus Announces the Clinical Launch of its Immune Profile Score Algorithmic Test November 07, 2024 From Tempus AI, Inc. Via Business Wire Tempus Reports Third Quarter 2024 Results and Agreement to Acquire Ambry Genetics November 04, 2024 From Tempus AI, Inc. Via Business Wire Tempus to Report Third Quarter 2024 Financial Results on November 4 November 03, 2024 From Tempus AI, Inc. Via Business Wire Tempus to Report Third Quarter 2024 Financial Results on November 7 October 24, 2024 From Tempus AI, Inc. Via Business Wire Tempus Announces Expansion of Collaboration with Takeda to Leverage Multimodal Real-World Datasets and Biological Model Systems in Oncology Research and Development September 26, 2024 From Tempus AI, Inc. Via Business Wire Tempus Launches Beta Version of olivia, its AI-enabled Personal Health Concierge App for Patients September 12, 2024 From Tempus AI, Inc. Via Business Wire Tempus Announces Real World Data Collaboration with BioNTech September 04, 2024 From Tempus AI, Inc. Via Business Wire Tempus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference August 28, 2024 From Tempus AI, Inc. Via Business Wire MarketBeat Week in Review – 8/19 - 8/23 August 24, 2024 Stocks closed the week higher on the near certainty that the Fed will cut interest rates in September, but in the short term, all eyes are on NVDA earnings Via MarketBeat Topics Economy Exposures Economy Interest Rates Biotech Stock Soars 60% in 2024: Cathie Wood’s Bold Investment August 23, 2024 Tempus AI is a hot healthcare stock that investors should be aware of. It is using AI to pursue "precision medicine", especially in cancer research. Via MarketBeat Topics Artificial Intelligence ETFs Exposures Artificial Intelligence NPJ Precision Oncology Publishes Tempus Study on Validation of its HLA-LOH Investigational Assay August 08, 2024 From Tempus AI, Inc. Via Business Wire Tempus Reports Second Quarter 2024 Results August 06, 2024 From Tempus AI, Inc. Via Business Wire Tempus Next Launches New Algorithm to Close Care Gaps in Guideline-Directed IHC Testing, Starting with HER2 August 01, 2024 From Tempus AI, Inc. Via Business Wire Tempus Announces Expanded Data and Sequencing Collaboration with Remix Therapeutics July 30, 2024 From Tempus AI, Inc. Via Business Wire Tempus to Report Second Quarter 2024 Financial Results on August 6 July 17, 2024 From Tempus AI, Inc. Via Business Wire Tempus Expands Immuno-Oncology Portfolio with Launch of AI-enabled, Multimodal Immune Profile Algorithmic Tests July 16, 2024 From Tempus AI, Inc. Via Business Wire Tempus Surpasses 500 Research Publications July 10, 2024 From Tempus AI, Inc. Via Business Wire American Medical Association Grants PLA Code to Tempus Algorithmic Test, PurISTSM July 08, 2024 From Tempus AI, Inc. Via Business Wire CMS Awards Tempus With Advanced Diagnostic Laboratory Test (ADLT) Status for its xT CDx Test July 02, 2024 From Tempus AI, Inc. Via Business Wire Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF, an AI-based Algorithm that Identifies Patients at Increased Risk of AFib June 26, 2024 From Tempus Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
